These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 26614034

  • 1. Current Clinical Applications of Testicular Cancer Biomarkers.
    Mir MC, Pavan N, Gonzalgo ML.
    Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
    [Abstract] [Full Text] [Related]

  • 2. MicroRNAs as Biomarkers for Germ Cell Tumors.
    Nappi L, Nichols C.
    Urol Clin North Am; 2019 Aug; 46(3):449-457. PubMed ID: 31277739
    [Abstract] [Full Text] [Related]

  • 3. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
    Rijlaarsdam MA, van Agthoven T, Gillis AJ, Patel S, Hayashibara K, Lee KY, Looijenga LH.
    Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?
    Belge G, Dieckmann KP, Spiekermann M, Balks T, Bullerdiek J.
    Eur Urol; 2012 May; 61(5):1068-9. PubMed ID: 22386195
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP.
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [Abstract] [Full Text] [Related]

  • 6. MicroRNAs in Testicular Cancer Diagnosis and Prognosis.
    Ling H, Krassnig L, Bullock MD, Pichler M.
    Urol Clin North Am; 2016 Feb; 43(1):127-34. PubMed ID: 26614035
    [Abstract] [Full Text] [Related]

  • 7. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A, Cremers JF, Kliesch S, Riek S, Junker K, Mohamed SA, Anheuser P, Belge G, Dieckmann KP.
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
    [Abstract] [Full Text] [Related]

  • 8. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J.
    J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
    [Abstract] [Full Text] [Related]

  • 9. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.
    Int J Mol Sci; 2018 Oct 12; 19(10):. PubMed ID: 30321995
    [Abstract] [Full Text] [Related]

  • 10. Testicular Germ Cell Tumors Go Epigenetics: Will miR-371a-3p Replace Classical Serum Biomarkers?
    Henrique R, Jerónimo C.
    Eur Urol; 2017 Feb 12; 71(2):221-222. PubMed ID: 27543167
    [No Abstract] [Full Text] [Related]

  • 11. Testicular cancer: a new generation of biomarkers for malignant germ cell tumours.
    Murray MJ, Coleman N.
    Nat Rev Urol; 2012 May 01; 9(6):298-300. PubMed ID: 22549310
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?
    Spiekermann M, Dieckmann KP, Balks T, Bullerdiek J, Belge G.
    Anticancer Res; 2015 Jan 01; 35(1):117-21. PubMed ID: 25550541
    [Abstract] [Full Text] [Related]

  • 14. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond.
    Egan J, Salari K.
    Urol Clin North Am; 2023 Feb 01; 50(1):133-143. PubMed ID: 36424077
    [Abstract] [Full Text] [Related]

  • 15. Serum tumor markers in the evaluation of male germ cell tumors.
    Barlow LJ, Badalato GM, McKiernan JM.
    Nat Rev Urol; 2010 Nov 01; 7(11):610-7. PubMed ID: 21068762
    [Abstract] [Full Text] [Related]

  • 16. Consensus statement on circulating tumour markers and staging patients with germ cell tumours.
    Rustin GJ, Vogelzang NJ, Sleijfer DT, Nisselbaum JN.
    Prog Clin Biol Res; 1990 Nov 01; 357():277-84. PubMed ID: 2170994
    [No Abstract] [Full Text] [Related]

  • 17. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
    Ellinger J, Albers P, Müller SC, von Ruecker A, Bastian PJ.
    BJU Int; 2009 Jul 01; 104(1):48-52. PubMed ID: 19154496
    [Abstract] [Full Text] [Related]

  • 18. Serum Levels of Trace Elements in Patients with Testicular Cancers.
    Kaba M, Pirinççi N, Yüksel MB, Gecit İ, Güneş M, Demir M, Akkoyun H, Demir H.
    Int Braz J Urol; 2015 Jul 01; 41(6):1101-7. PubMed ID: 26742967
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of Serum Biomarkers (FGF-2, HGF, MIF and PTN) in Patients With Testicular Germ Cell Cancer.
    Hauser S, Kaminski A, Syring I, Holdenrieder S, Dieckmann KP, Muller SC, Ellinger J.
    In Vivo; 2019 Jul 01; 33(6):1935-1940. PubMed ID: 31662522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.